Last $20.43 USD
Change Today -0.06 / -0.29%
Volume 78.2K
CMRX On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 5:20 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Raymund R. Razonable M.D.

Member of Clinical Advisory Board, Chimerix, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Dr. Raymund R. Razonable, M.D. is Associate Professor of Medicine at Mayo Clinic College of Medicine in Rochester Dr. Razonable has served as a reviewer for over 20 medical and scientific journals and is editor of Transplant Infectious Diseases. He is the associate chair for faculty development and diversity in the division of infectious diseases, and the chair of the transplant infectious diseases program. He serves as a Member of Clinical Advisory Board at Chimerix, ...

Read Full Background

Corporate Headquarters*

2505 Meridian Parkway
Durham, North Carolina 27713

United States

Phone: 919-806-1074
Fax: 919-806-1146

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CMRX:US $20.43 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Eric A. Rose M.D.Executive Chairman, Chief Executive Officer and Member of National Biodefense Science Board
SIGA Technologies, Inc.
$1.1M
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Peter Mørch Eriksen BBAChief Executive Officer and Administration Director
BioPorto A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHIMERIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.